Loading clinical trials...
Loading clinical trials...
Obesity and it's Impact on Subsidence and Clinical Outcomes After Short Stem Total Hip
The purpose of this study is to review the impact of obesity on subsidence and clinical outcome after short stem total hip arthroplasty.
Short stem total hip arthroplasty (THA) has gained popularity due to its bone-sparing technique, but its outcomes in obese patients remain uncertain. While studies on the mid-term outcome in a general patient cohort provide excellent results in terms of the clinical and radiological outcome as well as the complication rate of short stem THA, data on its use in obese patients is still rare and not sufficiently conclusive. Some studies have found no evidence of increased subsidence in obese patients, while other studies have shown contrary trends. In this context, the aim of this study was to investigate the relationship between BMI, postoperative subsidence and clinical outcomes in the setting of short stem THA.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Ordensklinikum Linz, Barmherzige Schwestern Abteilung Orthopädie
Linz, Austria
Start Date
January 1, 2018
Primary Completion Date
December 31, 2023
Completion Date
January 31, 2024
Last Updated
June 11, 2024
200
ACTUAL participants
Total hip arthroplasty
PROCEDURE
Lead Sponsor
Krankenhaus Barmherzige Schwestern Linz
NCT07472881
NCT01143454
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions